What is Macula Risk® PGx?
"Earlier detection, earlier treatment, better visual outcomes"
Macula Risk® PGx is a combined prognostic and pharmacogenetic DNA test for patients who have a diagnosis of early or intermediate Age-Related Macular Degeneration (AMD).
The sample is a simple cheek swab ordered by your doctor to determine:
- Patient's risk of progressing to advanced AMD within 2, 5 and 10 years using an analysis of specific AMD risk genes, clinical AMD status and significant non-genetic risk factors (age, smoking history and body mass index, or BMI).
- The appropriate eye vitamin therapy for maximum vision preservation based on the patient’s specific genetic profile.
Discuss with your doctor whether the Macula Risk PGx test is right for you.
For more information, visit www.macularisk.com or call 1-866-964-5182.